This federal contract award is for the delivery of 18 mg tablets of the prescription medication methylphenidate, a common treatment for attention-deficit/hyperactivity disorder (ADHD). The contract, valued at $1,223.14, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on December 10, 2024. This is a firm fixed-price delivery order with a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC contract.
Generated 3/11/25, 9:55 AM